Kevin Rouault-Pierre
@kevinrouault.bsky.social
Reader in SC biology /Group leader at Barts Cancer Institute - QMUL - Centre for Haemato-Onco #Stemcells #MDS #AML #Splicing #ERstress. Opinions are my own.
Great work! Well done @francescoterenzi.bsky.social
April 24, 2025 at 9:51 PM
Great work! Well done @francescoterenzi.bsky.social
Many thanks to @hemasphere-journal.bsky.social for their help and support during the whole process!
April 23, 2025 at 10:23 PM
Many thanks to @hemasphere-journal.bsky.social for their help and support during the whole process!
Thanks Diana!
March 25, 2025 at 4:13 PM
Thanks Diana!
4/4
📖 And fresh off the press in @hemasphere-journal.bsky.social : our new review with @ShoshanaBurke & @OnimaChowdhury— "Low-risk MDS: A spotlight on precision medicine for SF3B1-mutated patients", covering the biological & clinical landscape of SF3B1-MDS.
📢 #MDS #SF3B1
onlinelibrary.wiley...
📖 And fresh off the press in @hemasphere-journal.bsky.social : our new review with @ShoshanaBurke & @OnimaChowdhury— "Low-risk MDS: A spotlight on precision medicine for SF3B1-mutated patients", covering the biological & clinical landscape of SF3B1-MDS.
📢 #MDS #SF3B1
onlinelibrary.wiley...
Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients
A deep understanding of the biological mechanisms driving the pathogenesis of myelodysplastic neoplasms (MDS) is essential to develop comprehensive therapeutic approaches that will benefit patient's ...
onlinelibrary.wiley.com
March 22, 2025 at 3:38 PM
4/4
📖 And fresh off the press in @hemasphere-journal.bsky.social : our new review with @ShoshanaBurke & @OnimaChowdhury— "Low-risk MDS: A spotlight on precision medicine for SF3B1-mutated patients", covering the biological & clinical landscape of SF3B1-MDS.
📢 #MDS #SF3B1
onlinelibrary.wiley...
📖 And fresh off the press in @hemasphere-journal.bsky.social : our new review with @ShoshanaBurke & @OnimaChowdhury— "Low-risk MDS: A spotlight on precision medicine for SF3B1-mutated patients", covering the biological & clinical landscape of SF3B1-MDS.
📢 #MDS #SF3B1
onlinelibrary.wiley...
3/4
📝 Shoshana Burke, Clinical Research Fellow in the lab, wrote a great editorial in @hemasphere-journal.bsky.social on low-risk MDS—it’s a quick 2-minute read!
onlinelibrary.wiley.com/doi/10.1002/...
📝 Shoshana Burke, Clinical Research Fellow in the lab, wrote a great editorial in @hemasphere-journal.bsky.social on low-risk MDS—it’s a quick 2-minute read!
onlinelibrary.wiley.com/doi/10.1002/...
“Low‐risk” myelodysplastic neoplasm (MDS): Time for a name change?
Click on the article title to read more.
onlinelibrary.wiley.com
March 22, 2025 at 3:38 PM
3/4
📝 Shoshana Burke, Clinical Research Fellow in the lab, wrote a great editorial in @hemasphere-journal.bsky.social on low-risk MDS—it’s a quick 2-minute read!
onlinelibrary.wiley.com/doi/10.1002/...
📝 Shoshana Burke, Clinical Research Fellow in the lab, wrote a great editorial in @hemasphere-journal.bsky.social on low-risk MDS—it’s a quick 2-minute read!
onlinelibrary.wiley.com/doi/10.1002/...
2/4
🔬 Thanks to the #MDSUK Charity, we are developing a Vitamin B5 test and are now working towards a clinical trial based on our findings.
mdspatientsupport.org.uk...
🔬 Thanks to the #MDSUK Charity, we are developing a Vitamin B5 test and are now working towards a clinical trial based on our findings.
mdspatientsupport.org.uk...
MDS UK Funds Vitamin B5 Tests To Support A Clinical Trial Aiming To Relieve MDS-related Anaemia | MDS UK Patient Support Group
MDS UK funds Vitamin B5 study to alleviate MDS anaemia, led by Oxford University researchers, approved by Birmingham University Cancer Trials, starting Spring 2025.
mdspatientsupport.org.uk
March 22, 2025 at 3:38 PM
2/4
🔬 Thanks to the #MDSUK Charity, we are developing a Vitamin B5 test and are now working towards a clinical trial based on our findings.
mdspatientsupport.org.uk...
🔬 Thanks to the #MDSUK Charity, we are developing a Vitamin B5 test and are now working towards a clinical trial based on our findings.
mdspatientsupport.org.uk...
1/4
🩸 Following up on our work showing that Vitamin B5 can partially rescue ineffective erythropoiesis in SF3B1-MDS, we’ve just published our erythroid differentiation protocol in #JoVE! 🎉 Kudos to @celinephilippe.bsky.social & @ShoshanaBurke for making this happen!
www.jove.com...
www.science...
🩸 Following up on our work showing that Vitamin B5 can partially rescue ineffective erythropoiesis in SF3B1-MDS, we’ve just published our erythroid differentiation protocol in #JoVE! 🎉 Kudos to @celinephilippe.bsky.social & @ShoshanaBurke for making this happen!
www.jove.com...
www.science...
A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
www.jove.com
March 22, 2025 at 3:38 PM
1/4
🩸 Following up on our work showing that Vitamin B5 can partially rescue ineffective erythropoiesis in SF3B1-MDS, we’ve just published our erythroid differentiation protocol in #JoVE! 🎉 Kudos to @celinephilippe.bsky.social & @ShoshanaBurke for making this happen!
www.jove.com...
www.science...
🩸 Following up on our work showing that Vitamin B5 can partially rescue ineffective erythropoiesis in SF3B1-MDS, we’ve just published our erythroid differentiation protocol in #JoVE! 🎉 Kudos to @celinephilippe.bsky.social & @ShoshanaBurke for making this happen!
www.jove.com...
www.science...